Yubin Miao Selected Research

lysinenorleucine

6/2012	Gallium-67-labeled lactam bridge-cyclized alpha-MSH peptides with enhanced melanoma uptake and reduced renal uptake.
11/2009	Effect of DOTA position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide.
4/2009	Metastatic melanoma imaging with an (111)In-labeled lactam bridge-cyclized alpha-melanocyte-stimulating hormone peptide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yubin Miao Research Topics

Disease

50	Melanoma (Melanoma, Malignant) 02/2022 - 02/2002
32	Neoplasms (Cancer) 02/2022 - 02/2002
5	Prostatic Neoplasms (Prostate Cancer) 07/2018 - 09/2011
3	Glioblastoma (Glioblastoma Multiforme) 07/2018 - 02/2014
2	Breast Neoplasms (Breast Cancer) 02/2014 - 08/2011

Drug/Important Bio-Agent (IBA)

54	Peptides (Polypeptides)IBA 02/2022 - 02/2002
35	alpha-MSHIBA 02/2022 - 02/2002
27	Type 1 Melanocortin ReceptorIBA 02/2022 - 11/2003
19	LactamsIBA 01/2022 - 02/2008
15	AcidsIBA 02/2022 - 08/2005
14	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 02/2002
14	Melanocyte-Stimulating Hormones (MSH)IBA 01/2022 - 08/2009
11	Radioisotopes (Radionuclides)IBA 01/2021 - 02/2002
7	RadiopharmaceuticalsIBA 01/2021 - 07/2002
7	arginylprolineIBA 11/2014 - 04/2009
6	triazacyclononaneIBA 01/2022 - 06/2012
6	Amino Acids FDA Link 12/2014 - 10/2002
5	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2022 - 06/2012
5	IntegrinsIBA 01/2021 - 11/2010
5	N-glycylglutamic acidIBA 06/2012 - 02/2008
4	Chelating AgentsIBA 12/2020 - 05/2009
4	MetalsIBA 01/2020 - 02/2002
4	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2017 - 08/2011
4	arginyl-glycyl-aspartic acidIBA 04/2015 - 08/2009
3	cysteinylcysteineIBA 11/2014 - 09/2013
3	lysinenorleucineIBA 06/2012 - 04/2009
3	RheniumIBA 11/2007 - 02/2002
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022 - 12/2014
2	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 12/2020 - 01/2020
2	BombesinIBA 07/2018 - 02/2015
2	tryptophylglycineIBA 06/2012 - 11/2009
2	Ac- Cys- Cys- Glu- His- D- Phe- Arg- Trp- Cys- Lys- Pro- Val- NH2IBA 11/2010 - 08/2006
2	Lysine (L-Lysine)FDA Link 11/2007 - 10/2002
2	Therapeutic UsesIBA 06/2007 - 01/2005
2	1,4,7,10-tetraazacyclododecane 1,4,7,10-tetraacetic acid (ReO- acetyl(Cys(3,4,10),Phe(7),Arg(7))alpha- MSH(3- 13))IBA 01/2007 - 04/2005
1	AlbuminsIBA 02/2022
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2022
1	Integrin alpha4beta1 (VLA-4)IBA 01/2021
1	phenylalanylarginineIBA 12/2020
1	LigandsIBA 02/2015
1	Bombesin Receptors (Bombesin Receptor)IBA 02/2015
1	omega-aminocaprylic acidIBA 12/2014
1	EDDA (NiEDDA)IBA 12/2014
1	HydrocarbonsIBA 12/2014
1	MelanocortinsIBA 11/2014
1	aspartyllysineIBA 11/2013
1	alanylaspartic acidIBA 02/2012
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 08/2011
1	N- (2- amino- 3- (4- isothiocyanatophenyl)propyl)cyclohexane- 1,2- diamine- N,N',N',N'',N''- pentaacetic acidIBA 05/2009
1	N- (2- aminoethyl)- 1,2- diaminocyclohexane- N,N',N''- pentaacetic acid-Re(Cys(3,4,10))-Phe(7)-Arg(11)- alpha-MSH(3-13)IBA 05/2009
1	ACTH (7-10)IBA 04/2009
1	Deoxyglucose (2 Deoxy D glucose)IBA 04/2009
1	Melanins (Melanin)IBA 09/2008
1	PlacebosIBA 06/2007
1	AntigensIBA 03/2007
1	Biomarkers (Surrogate Marker)IBA 03/2007
1	Peptide LibraryIBA 03/2007
1	StreptavidinIBA 03/2007
1	Glutamic Acid (Glutamate)FDA Link 08/2006
1	Oxygen (Dioxygen)IBA 08/2005
1	OF 900IBA 11/2003
1	Indium-111IBA 02/2002

Therapy/Procedure

19	Therapeutics 01/2022 - 10/2002
3	Intravenous Injections 07/2018 - 02/2014
3	Radiotherapy 02/2014 - 02/2002
2	Precision Medicine 01/2022 - 07/2018
1	Aftercare (After-Treatment) 01/2005